This interview provides perspective on developments in breast cancer treatment in 2017, as well as a preview of what we can expect to change in the treatment of breast cancer in 2018.
Oncology Vol 31 No 12_Suppl_1
Advertisement
Advertisement
Trending on CancerNetwork
1
Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ
2
Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance
3
Subcutaneous Isatuximab May Optimize Multiple Myeloma Treatment Protocols
4
Investigational Radioenhancer Shows Feasibility in Stage III NSCLC
5